Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy

被引:81
作者
Dubois, RW [1 ]
Melmed, GY
Henning, JM
Laine, L
机构
[1] Zynx Hlth Inc, Beverly Hills, CA 90212 USA
[2] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA
[3] TAP Phamraceut Prod Inc, Med Affairs Dept, Lake Forest, IL USA
[4] Univ So Calif, Sch Med, Los Angeles, CA 90089 USA
关键词
D O I
10.1111/j.0269-2813.2004.01834.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: To rationalize decision making around the use of different non-steroidal anti-inflammatory drug (NSAID) treatment strategies in patients with varying degrees of gastrointestinal and cardiovascular risk. Methods: The panel comprised nine physicians (three rheumatologists, two internists, two gastroenterologists and two cardiologists) from geographically diverse areas practising in community-based settings (n = 4) and academic institutions (n = 5). A literature review was performed by the authors on the risks, benefits and costs of NSAIDs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitor co-therapy. The RAND/UCLA Appropriateness Method was used to rate 304 clinical scenarios as 'appropriate', 'uncertain' or 'inappropriate'. Results: In patients with no previous gastrointestinal event and not concurrently on aspirin (low risk), the panel rated the use of an NSAID alone as 'appropriate' for those aged < 65 years, and the use of an NSAID +proton pump inhibitor or cyclo-oxygenase-2-specific inhibitor + proton pump inhibitor as 'inappropriate'. For patients aged > 65 years and at low risk, an NSAID or cyclo-oxygenase-2-specific inhibitor alone was rated as 'uncertain'. For patients with a previous gastrointestinal event or who concurrently received aspirin, an NSAID alone was rated as 'inappropriate', and either a cyclo-oxygenase-2-specific inhibitor or an NSAID +proton pump inhibitor was rated as 'appropriate'. Finally, for patients with a previous gastrointestinal event and on aspirin, an NSAID or cyclo-oxygenase-2-specific inhibitor in conjunction with a proton pump inhibitor was rated as 'appropriate'. Conclusions: Clinicians and managed care entities need to balance the risks, benefits and costs of NSAIDs, cyclo-oxygenase-2-specific inhibitors and the prophylactic use of proton pump inhibitors. The guidelines given here can assist this process.
引用
收藏
页码:197 / 208
页数:12
相关论文
共 51 条
[1]  
[Anonymous], 1998, The American Journal of Medicine, DOI DOI 10.1016/S0002-9343(97)00207-6
[2]   SIDE-EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON THE SMALL AND LARGE-INTESTINE IN HUMANS [J].
BJARNASON, I ;
HAYLLAR, J ;
MACPHERSON, AJ ;
RUSSELL, AS .
GASTROENTEROLOGY, 1993, 104 (06) :1832-1847
[3]  
Bloom B S, 1988, Am J Med, V84, P20, DOI 10.1016/0002-9343(88)90250-1
[4]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[5]   Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen [J].
Chan, FKL ;
Chung, SCS ;
Suen, BY ;
Lee, YT ;
Leung, WK ;
Leung, VKS ;
Wu, JCY ;
Lau, JYW ;
Hui, Y ;
Lai, MS ;
Chan, HLY ;
Sung, JJY .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (13) :967-973
[6]   Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis [J].
Derry, S ;
Loke, YK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7270) :1183-+
[7]   RISK FOR SERIOUS GASTROINTESTINAL COMPLICATIONS RELATED TO USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A METAANALYSIS [J].
GABRIEL, SE ;
JAAKKIMAINEN, L ;
BOMBARDIER, C .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (10) :787-796
[8]  
Goldstein JL, 2000, AM J GASTROENTEROL, V95, P1681
[9]  
GOLDSTEIN JL, 2001, SUCCESS OSTEOARTHRIT
[10]   Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs - Results of a double-blind, randomized,, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole [J].
Graham, DY ;
Agrawal, NM ;
Campbell, DR ;
Haber, MM ;
Collis, C ;
Lukasik, NL ;
Huang, B .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (02) :169-175